Top Markets
#1 Cross Cross +12.78%
#2 Casper Network Casper Network +11.85%
#3 Gama Token Gama Token +9.13%
#4 龙虾 (Lobster) 龙虾 (Lobster) +5.14%
#5 Perle Perle +4.54%
#6 Berachain Berachain +4.52%
#7 Akedo Akedo +4.17%
#8 Humanity Humanity +3.77%
#9 The Innovation Game The Innovation Game +3.74%
#10 Palladium Network Palladium Network +3.67%
Coin of the day
Cross Cross
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc.

FRTX
Kedudukan dalam Saham #36397
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused... Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.
Harga Saham
$0.94
Disegerakkan terakhir: 2025-02-28
Modal Pasaran
$2.73M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Fresh Tracks Therapeutics, Inc. (FRTX)

Kategori

Healthcare
Bilangan saham terbitan bagi Fresh Tracks Therapeutics, Inc. (FRTX)
Bilangan saham terbitan setakat December 2023: 5.91M
Menurut laporan kewangan terkini dan harga saham Fresh Tracks Therapeutics, Inc., bilangan saham terbitan semasa ialah 5.91M. Pada akhir December 2022, syarikat mempunyai 2.81M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Fresh Tracks Therapeutics, Inc. (FRTX) dari 2000 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 5.91M 0.00%
2023 5.91M 110.56%
2022 2.81M 57.33%
2021 1.78M 227.63%
2020 544.76K 710.92%
2019 67.18K -3.12%
2018 69.34K 69.47%
2017 40.91K 28.64%
2016 31.81K 9.20%
2015 29.13K 3.33%
2014 28.19K 2.24%
2013 27.57K 1.02%
2012 27.29K 19.35%
2011 22.87K 19.88%
2010 19.07K 27.61%
2009 14.95K 18.14%
2008 12.65K 1.70%
2007 12.44K 24.67%
2006 9.98K 27.89%
2005 7.80K 8.31%
2004 7.20K 12.95%
2003 6.38K 0.06%
2002 6.37K 0.24%
2001 6.36K 1.74%
2000 6.25K 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 4,194.08%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 951.71%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE